Speaker

Karin de Visser is group leader in the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute (NKI) in Amsterdam and Oncode Institute, and a full professor of Experimental Immunobiology of Cancer at Leiden University Medical Center. Her lab investigates how the immune system influences breast cancer metastasis and therapy response. Her lab has revealed how tumor-induced systemic inflammation drives neutrophil-dependent immunosuppression and promotes metastasis. By integrating tumor immunology and cancer genetics, her team demonstrated that the genetic make-up of breast cancer shapes the immune landscape. In collaboration with Dr. Marleen Kok, her team also uncovered a critical role for eosinophils in immunotherapy response of breast cancer. Karin de Visser recently received the Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award (2025) and the Josephine Nefkens Award (2025).

« Go Back